TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 72 filers reported holding TAYSHA GENE THERAPIES INC in Q1 2022. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $120,648 | +520.2% | 38,180 | +29.7% | 0.00% | – |
| Q2 2023 | $19,454 | -82.2% | 29,431 | -78.5% | 0.00% | – |
| Q1 2023 | $109,190 | -4.1% | 137,001 | +172.0% | 0.00% | – |
| Q4 2022 | $113,850 | -15.0% | 50,376 | -27.5% | 0.00% | – |
| Q3 2022 | $134,000 | -45.5% | 69,505 | +5.2% | 0.00% | – |
| Q2 2022 | $246,000 | -47.1% | 66,043 | -7.4% | 0.00% | – |
| Q1 2022 | $465,000 | -35.2% | 71,358 | +15.8% | 0.00% | – |
| Q4 2021 | $718,000 | +18.1% | 61,646 | +88.7% | 0.00% | – |
| Q3 2021 | $608,000 | +17.6% | 32,677 | +34.0% | 0.00% | – |
| Q2 2021 | $517,000 | +71.8% | 24,379 | +64.1% | 0.00% | – |
| Q1 2021 | $301,000 | +73.0% | 14,855 | +126.6% | 0.00% | – |
| Q4 2020 | $174,000 | – | 6,556 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,827,926 | $12,096,246 | 8.11% |
| TCG Crossover Management, LLC | 11,111,111 | $35,111,111 | 5.17% |
| VR Adviser, LLC | 14,444,444 | $45,644,443 | 4.80% |
| Kynam Capital Management, LP | 3,281,313 | $10,368,949 | 1.70% |
| Ghost Tree Capital, LLC | 1,325,000 | $4,187,000 | 1.38% |
| Octagon Capital Advisors LP | 2,777,778 | $8,777,778 | 1.35% |
| RA Capital Management | 18,472,503 | $58,373,109 | 1.15% |
| RTW INVESTMENTS, LP | 16,893,185 | $53,382,465 | 1.13% |
| Diametric Capital, LP | 760,014 | $2,401,644 | 1.00% |
| Quantum Private Wealth, LLC | 575,380 | $1,818,201 | 0.87% |